HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent Filings Up As Industry Continues Investing In Nanotech Research

This article was originally published in The Rose Sheet

Executive Summary

Despite regulatory uncertainty surrounding the use of nanotechnology in cosmetics, industry continues to study the tiny particles and to introduce new products that feature them, according to Charles Brumlik, a principal with consulting firm Nanobiz LLC

You may also be interested in...



L’Oreal Localizing R&D In Emerging Markets To Achieve Growth Objectives

To meet its goal of reaching 1 billion new customers over the next 10 years, L’Oreal’s new strategy calls for a localized research and development approach in emerging markets.

L’Oreal Localizing R&D In Emerging Markets To Achieve Growth Objectives

To meet its goal of reaching 1 billion new customers over the next 10 years, L’Oreal’s new strategy calls for a localized research and development approach in emerging markets.

FDA Committed To Advancing Its Regulatory Science Capacity

FDA cites "advances in the application of nanotechnology" among scientific "breakthroughs" that are revolutionizing the health-care community's ability to treat disease, making the notion of personalized care a reality and demanding more FDA involvement

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel